Health TrialsbyHealthPanel

GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of Adult Acute Lymphoblastic Leukemia (ALL) Patients and Related Diseases Associated With a Prospective Collection of Biomaterial

ConditionsAcute Lymphoblastic LeukemiaLeukemiaNon-Hodgkin's Lymphoma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorGoethe University

About this trial

The GMALL registry serves the purpose of ALL research and quality assurance. The Registry collects data about diagnostics, treatment and outcome of Adult ALL Patients in the clinical routine, whether or not the patient is treated within a clinical trial.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Acute Lymphoblastic Leukemia (All Subtypes) if treated according to ALL protocols

Other Types of Leukemia (NK Cell Lymphoma/Leukemia, Biphenotypic Acute Leukemia) if treated according to ALL protocols

Non-Hodgkin's Lymphoma of Following Subtypes: Burkitt Lymphoma, B Cell Lymphoma, B- or T-lineage Lymphoblastic Lymphoma, Anaplastic Large Cell Lymphoma, Other NHL) if treated according to B-ALL protocols

Age minimum 18 yrs

Disqualifiers

None

Trial population

Acute Lymphoblastic Leukemia or seleted NHL

Trial design

Design model

Other

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

10,000 Participants
are grouped into 2 trial groups
Group A: B-ALL/NHL
Group B: ALL/ Lymphoblastic Lymphoma (LBL)

Trial outcomes

Primary outcomes

1

Overall survival

Time frame
up to 10 years

Secondary outcomes

1

Event free survival

Time frame
up to 10 years
2

Hematologic remission rate

Time frame
after induction and consolidation, approximately 6 - 8 weeks from diagnosis
3

Molecular remission rate

Time frame
after induction and consolidation, approximately 6 - 8 weeks from diagnosis
4

Positron Emission Tomography (PET) based remission evaluation

Time frame
after induction and consolidation, approximately 6 - 8 weeks from diagnosis

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Goethe University

Lead sponsor

Source ClinicalTrials.gov
Apply now